DoseOptics
US-based start-up innovating real-time imaging technology for radiation therapy in cancer treatment.
Founded
2015US-based start-up innovating real-time imaging technology for radiation therapy in cancer treatment.
DoseOptics, founded in Lebanon, United States, is a pioneering startup focused on revolutionizing cancer treatment through innovative imaging technology. The company's core mission is to enhance the precision and effectiveness of radiation therapy by providing real-time imaging solutions. Their flagship product, Beamsite, enables clinicians to visualize and verify radiation therapy in real-time, ensuring that patients receive the most accurate and effective treatment possible. DoseOptics primarily targets the healthcare market, specifically oncology departments in hospitals and cancer treatment centers.
Notable figures associated with DoseOptics include leading experts in medical imaging and radiation therapy. The company has garnered attention from prominent investors in the healthcare technology sector, contributing to its rapid growth and development. Key achievements include successful clinical trials and partnerships with major research institutions, underscoring the efficacy and reliability of their technology. Overall, DoseOptics has made a significant impact by improving the quality of cancer care and advancing the capabilities of radiation therapy.
Companies similar to DoseOptics include Real Time Imaging Technologies, Radiosight, ViewRay and Voximetry.
DoseOptics was founded in 2015.
DoseOptics' headquarters is located in Lebanon, NH, US.
DoseOptics' most recent funding round was for $2M (USD) in October 2016.
As of Oct 1, 2016, DoseOptics has disclosed funding of $3.4M (USD). Undisclosed round amounts are excluded.
DoseOptics has 6 employees as of Feb 4, 2024.
voximetry.com
